BANK OF MONTREAL /CAN/ - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 275 filers reported holding FATE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.99 and the average weighting 0.7%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$933,000
-59.4%
11,805
-42.5%
0.00%
-100.0%
Q4 2020$2,297,000
+1564.5%
20,514
+517.3%
0.00%
Q3 2020$138,000
-23.8%
3,323
-33.4%
0.00%
Q2 2020$181,000
+20.7%
4,988
-34.8%
0.00%
Q4 2019$150,000
+111.3%
7,656
+66.8%
0.00%
Q3 2019$71,000
-20.2%
4,589
+4.8%
0.00%
Q2 2019$89,0004,378
+43680.0%
0.00%
Q1 2019$0
-100.0%
10
-99.4%
0.00%
Q4 2018$20,000
+17.6%
1,554
+48.9%
0.00%
Q3 2018$17,000
+41.7%
1,044
+1.5%
0.00%
Q2 2018$12,000
+71.4%
1,029
+51.3%
0.00%
Q1 2018$7,000
-61.1%
680
-77.3%
0.00%
Q4 2017$18,0003,000
+17547.1%
0.00%
Q3 2017$017
+30.8%
0.00%
Q4 2016$013
-7.1%
0.00%
Q3 2016$014
-95.1%
0.00%
Q2 2016$0285
+3971.4%
0.00%
Q1 2016$07
-41.7%
0.00%
Q4 2015$012
-61.3%
0.00%
Q3 2015$031
+34.8%
0.00%
Q2 2015$0
-100.0%
23
-98.8%
0.00%
Q1 2015$10,0002,0000.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$7,163,6162.64%
Redmile Group, LLC 13,124,427$27,823,7851.32%
Monaco Asset Management SAM 1,847,944$3,917,6411.16%
Casdin Capital, LLC 2,050,000$4,346,0000.48%
TANG CAPITAL MANAGEMENT LLC 700,000$1,484,0000.21%
GCM Grosvenor Holdings, LLC 495,916$1,051,3420.21%
Nebula Research & Development LLC 163,617$346,8680.18%
Bellevue Group AG 4,851,579$10,285,3470.17%
Bruce & Co., Inc. 200,000$424,0000.14%
XTX Topco Ltd 192,920$408,9900.07%
View complete list of FATE THERAPEUTICS INC shareholders